BackStarling Oncology Overview

Starling Oncology Intangible Assets

Track Starling Oncology's intangible assets ($9.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$9.59M
↓ 23.01% YoYΔ $-2.86M vs prior year quarter

Peer trimmed avg / median

Loading

Starling Oncology Intangible Assets History

Loading

Starling Oncology vs. peers: Intangible Assets Comparison

Loading

Starling Oncology Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Starling Oncology (STLN) FAQ

Starling Oncology (STLN) currently reports a intangible assets of $9.6M as of June 2026. That compares with $12M in the prior-year period — down 23.0% year over year. Use the charts on this page to explore Starling Oncology's intangible assets history and peer comparisons.

Starling Oncology's intangible assets decreased from $12M to $9.6M — a 23.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Starling Oncology reported $9.6M in intangible assets as of June 2026. That compares with $12M in the prior-year period — down 23.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $9.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Starling Oncology, and consider following STLN for alerts when major investors trade the stock.